Back to search

Article

Clinical and experimental evidence suggest omicron SARS-CoV-2 is inherently less pathogenic than delta independent of previous immunity

2022-11-15

Abstract excerpt

<h4>Objective: </h4> -To study clinical disease outcomes in both humans and animal models to understand the pathogenicity of omicron compared to delta variant. Methods- In this cross-sectional observational study, clinical outcomes of adults who tested positive at 2 testing centres in Delhi National Capital Region between January 2022 and March 2022 (Omicron infected; N=2998) were compared to a similar geographica...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a869dc2f-b4bf-5e68-9dba-6cf00ae43ad0
DOI
10.21203/rs.3.rs-2258374/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical and experimental evidence suggest omicron SARS-CoV-2 is inherently less pathogenic than delta independent of previous immunityDOI 10.21203/rs.3.rs-2258374/v1
Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunitySemantic proximity
Is Omicron really mild? - Comparative analysis of comorbidities and disease outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variantsSemantic proximity
Comparative analysis of the outcomes of COVID-19 between patients infected with SARS-CoV-2 Omicron and Delta variants: a retrospective cohort studySemantic proximity
Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in NorwaySemantic proximity
Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021 – January 2022: a retrospective, population-based, matched cohort studySemantic proximity
An Overview on SARS-CoV-2 Variants from Alpha to Omicron: Epidemiology, Treatment Plans and Preventive Strategies for Future PandemicSemantic proximity
Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and preventionSemantic proximity
The SARS-CoV-2 Omicron (B.1.1.529) variant exhibits altered pathogenicity, transmissibility, and fitness in the golden Syrian hamster modelSemantic proximity
The potential impact of Omicron and future variants of concern on SARS-CoV-2 transmission dynamics and public health burden: a modelling studySemantic proximity
SARS-CoV-2 variants show a gradual declining pathogenicity and pro-inflammatory cytokine spur, an increasing antigenic and antiinflammatory cytokine induction, and rising structural protein instabilitySemantic proximity
The Delta and Omicron Variants of SARS-CoV-2: What We Know So FarSemantic proximity
Reduced Risk of Hospitalisation Associated With Infection With SARS-CoV-2 Omicron Relative to Delta: A Danish Cohort StudySemantic proximity
Select a neighboring publication to make it the new centre.